Cargando…
Systematic Pharmacogenomics Analysis of a Malay Whole Genome: Proof of Concept for Personalized Medicine
BACKGROUND: With a higher throughput and lower cost in sequencing, second generation sequencing technology has immense potential for translation into clinical practice and in the realization of pharmacogenomics based patient care. The systematic analysis of whole genome sequences to assess patient t...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751891/ https://www.ncbi.nlm.nih.gov/pubmed/24009664 http://dx.doi.org/10.1371/journal.pone.0071554 |
_version_ | 1782281695060295680 |
---|---|
author | Salleh, Mohd Zaki Teh, Lay Kek Lee, Lian Shien Ismet, Rose Iszati Patowary, Ashok Joshi, Kandarp Pasha, Ayesha Ahmed, Azni Zain Janor, Roziah Mohd Hamzah, Ahmad Sazali Adam, Aishah Yusoff, Khalid Hoh, Boon Peng Hatta, Fazleen Haslinda Mohd Ismail, Mohamad Izwan Scaria, Vinod Sivasubbu, Sridhar |
author_facet | Salleh, Mohd Zaki Teh, Lay Kek Lee, Lian Shien Ismet, Rose Iszati Patowary, Ashok Joshi, Kandarp Pasha, Ayesha Ahmed, Azni Zain Janor, Roziah Mohd Hamzah, Ahmad Sazali Adam, Aishah Yusoff, Khalid Hoh, Boon Peng Hatta, Fazleen Haslinda Mohd Ismail, Mohamad Izwan Scaria, Vinod Sivasubbu, Sridhar |
author_sort | Salleh, Mohd Zaki |
collection | PubMed |
description | BACKGROUND: With a higher throughput and lower cost in sequencing, second generation sequencing technology has immense potential for translation into clinical practice and in the realization of pharmacogenomics based patient care. The systematic analysis of whole genome sequences to assess patient to patient variability in pharmacokinetics and pharmacodynamics responses towards drugs would be the next step in future medicine in line with the vision of personalizing medicine. METHODS: Genomic DNA obtained from a 55 years old, self-declared healthy, anonymous male of Malay descent was sequenced. The subject's mother died of lung cancer and the father had a history of schizophrenia and deceased at the age of 65 years old. A systematic, intuitive computational workflow/pipeline integrating custom algorithm in tandem with large datasets of variant annotations and gene functions for genetic variations with pharmacogenomics impact was developed. A comprehensive pathway map of drug transport, metabolism and action was used as a template to map non-synonymous variations with potential functional consequences. PRINCIPAL FINDINGS: Over 3 million known variations and 100,898 novel variations in the Malay genome were identified. Further in-depth pharmacogenetics analysis revealed a total of 607 unique variants in 563 proteins, with the eventual identification of 4 drug transport genes, 2 drug metabolizing enzyme genes and 33 target genes harboring deleterious SNVs involved in pharmacological pathways, which could have a potential role in clinical settings. CONCLUSIONS: The current study successfully unravels the potential of personal genome sequencing in understanding the functionally relevant variations with potential influence on drug transport, metabolism and differential therapeutic outcomes. These will be essential for realizing personalized medicine through the use of comprehensive computational pipeline for systematic data mining and analysis. |
format | Online Article Text |
id | pubmed-3751891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-37518912013-09-05 Systematic Pharmacogenomics Analysis of a Malay Whole Genome: Proof of Concept for Personalized Medicine Salleh, Mohd Zaki Teh, Lay Kek Lee, Lian Shien Ismet, Rose Iszati Patowary, Ashok Joshi, Kandarp Pasha, Ayesha Ahmed, Azni Zain Janor, Roziah Mohd Hamzah, Ahmad Sazali Adam, Aishah Yusoff, Khalid Hoh, Boon Peng Hatta, Fazleen Haslinda Mohd Ismail, Mohamad Izwan Scaria, Vinod Sivasubbu, Sridhar PLoS One Research Article BACKGROUND: With a higher throughput and lower cost in sequencing, second generation sequencing technology has immense potential for translation into clinical practice and in the realization of pharmacogenomics based patient care. The systematic analysis of whole genome sequences to assess patient to patient variability in pharmacokinetics and pharmacodynamics responses towards drugs would be the next step in future medicine in line with the vision of personalizing medicine. METHODS: Genomic DNA obtained from a 55 years old, self-declared healthy, anonymous male of Malay descent was sequenced. The subject's mother died of lung cancer and the father had a history of schizophrenia and deceased at the age of 65 years old. A systematic, intuitive computational workflow/pipeline integrating custom algorithm in tandem with large datasets of variant annotations and gene functions for genetic variations with pharmacogenomics impact was developed. A comprehensive pathway map of drug transport, metabolism and action was used as a template to map non-synonymous variations with potential functional consequences. PRINCIPAL FINDINGS: Over 3 million known variations and 100,898 novel variations in the Malay genome were identified. Further in-depth pharmacogenetics analysis revealed a total of 607 unique variants in 563 proteins, with the eventual identification of 4 drug transport genes, 2 drug metabolizing enzyme genes and 33 target genes harboring deleterious SNVs involved in pharmacological pathways, which could have a potential role in clinical settings. CONCLUSIONS: The current study successfully unravels the potential of personal genome sequencing in understanding the functionally relevant variations with potential influence on drug transport, metabolism and differential therapeutic outcomes. These will be essential for realizing personalized medicine through the use of comprehensive computational pipeline for systematic data mining and analysis. Public Library of Science 2013-08-23 /pmc/articles/PMC3751891/ /pubmed/24009664 http://dx.doi.org/10.1371/journal.pone.0071554 Text en © 2013 Salleh et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Salleh, Mohd Zaki Teh, Lay Kek Lee, Lian Shien Ismet, Rose Iszati Patowary, Ashok Joshi, Kandarp Pasha, Ayesha Ahmed, Azni Zain Janor, Roziah Mohd Hamzah, Ahmad Sazali Adam, Aishah Yusoff, Khalid Hoh, Boon Peng Hatta, Fazleen Haslinda Mohd Ismail, Mohamad Izwan Scaria, Vinod Sivasubbu, Sridhar Systematic Pharmacogenomics Analysis of a Malay Whole Genome: Proof of Concept for Personalized Medicine |
title | Systematic Pharmacogenomics Analysis of a Malay Whole Genome: Proof of Concept for Personalized Medicine |
title_full | Systematic Pharmacogenomics Analysis of a Malay Whole Genome: Proof of Concept for Personalized Medicine |
title_fullStr | Systematic Pharmacogenomics Analysis of a Malay Whole Genome: Proof of Concept for Personalized Medicine |
title_full_unstemmed | Systematic Pharmacogenomics Analysis of a Malay Whole Genome: Proof of Concept for Personalized Medicine |
title_short | Systematic Pharmacogenomics Analysis of a Malay Whole Genome: Proof of Concept for Personalized Medicine |
title_sort | systematic pharmacogenomics analysis of a malay whole genome: proof of concept for personalized medicine |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751891/ https://www.ncbi.nlm.nih.gov/pubmed/24009664 http://dx.doi.org/10.1371/journal.pone.0071554 |
work_keys_str_mv | AT sallehmohdzaki systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine AT tehlaykek systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine AT leelianshien systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine AT ismetroseiszati systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine AT patowaryashok systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine AT joshikandarp systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine AT pashaayesha systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine AT ahmedaznizain systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine AT janorroziahmohd systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine AT hamzahahmadsazali systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine AT adamaishah systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine AT yusoffkhalid systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine AT hohboonpeng systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine AT hattafazleenhaslindamohd systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine AT ismailmohamadizwan systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine AT scariavinod systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine AT sivasubbusridhar systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine |